HRSA HIV/AIDS Bureau Special Sessions
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
Guide on how to implement an opt-out HIV testing program in a jail setting.
Resource updated 09/19/2023
Resource updated 03/15/2023
Event updated 02/21/2023
Resource updated 10/18/2023
The RUSH intervention facilitates linkage to and retention in care through an opt-out HIV te
Resource updated 09/14/2023
Learn about best practices for improving the quality of oral healthcare from a tested delivery model at Grady Health System. A presentation on HAB's performance measures for oral health and the utilization of data to improve care will also be shared.
Resource (Conference Presentation) updated 09/14/2023
In a multi-site community health center system, the most challenging patients with HIV and hepatitis C (HCV) co-infection were assessed for HICV cure, and the solutions developed to overcome their barriers to treatment were translated into systems change. The presenters will discuss the challenges, solutions, and resultant system changes.
Resource (Conference Presentation) updated 09/14/2023
All RWHAP recipients and providers will experience an increase in their aging population and will need to respond. This session will give a firsthand perspective on aging with HIV, provide an overview of RWHAP aging data, summarize medical conditions and psychosocial needs facing aging clients, and review HRSA initiatives.
Resource (Conference Presentation) updated 09/14/2023
Discuss the role of the geriatrician and roles that can be transferred to other staff; review the geriatric screenings and assessments and staff who can perform the screenings and assessments; share models where geriatric services were integrated into the clinic; and provide information about the experience of receiving integrated services.
Resource (Conference Presentation) updated 09/14/2023
This session will discuss the landscape of community aging resources and partnerships available within jurisdictions, explore methods to identify and develop partnerships with community aging resources, and focus on the experiences of RWHAP recipients, providers, and people aging with HIV in identifying community aging resources, developing community aging partnerships, and utilizing community aging resources.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Establishing an opt-out HIV screening program in the emergency department has almost quadrupled HIV screening rates and has identified new and out-of-care cases. Utilizing a continuous quality improvement approach has allowed it to become a catalyst to improve workflows for other gaps in University Medical Center of Southern Nevada's HIV care continuum process.
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will review updated data and discuss implementation challenges, facilitators, and best practices for routine screening/linkage in an emergency department with urban and rural challenges. Preliminary data from the initial two months (with more than 2,000 patients screened) include .7% HIV (including three acute infections), 7% Hepatitis C (HCV) and 5.2% syphilis.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023